Nanoscope strengthens_thumbnail
September 4, 2025

Nanoscope Secures Major Global Wins for MCO-010 with EMA and FDA Designations

The race to restore sight for patients living with retinal degeneration just gained serious momentum.  Nanoscope Therapeutics (Texas, United States)…

thumbnail (2)
September 4, 2025

Retinal Imaging and AI-Powered Analysis in the Palm of Your Hand

Sponsored by Optomed Accessibility, quality optics and AI combine to enable oculomics in Optomed’s newest handheld fundus camera Optomed Lumo…

popular posts
thumbnail (2)
September 4, 2025

Retinal Imaging and AI-Powered Analysis in the Palm of Your Hand

ENCELTO implant releasing neurotrophic factor
August 15, 2025

U.S. Patient Receives World’s First ENCELTO Gene Therapy for MacTel

latest posts
Nanoscope strengthens_thumbnail
September 4, 2025

Nanoscope Secures Major Global Wins for MCO-010 with EMA and FDA Designations

thumbnail (2)
September 4, 2025

Retinal Imaging and AI-Powered Analysis in the Palm of Your Hand

Radiation Maculopathy Formally _thumbnail
August 28, 2025

Radiation Maculopathy Formally Recognized as Roca Therapeutics Wins First EMA Orphan Nod for RCT002

first patients treated in jCyte_Thumbnail
August 20, 2025

First Patients Dosed in jCyte’s Phase II JC02-88 Trial for Retinitis Pigmentosa

ENCELTO implant releasing neurotrophic factor
August 15, 2025

U.S. Patient Receives World’s First ENCELTO Gene Therapy for MacTel

FDA handheld AI screening device_thumbnail
August 4, 2025

FDA Clears Optomed’s Handheld AI Screening Device for Diabetic Retinopathy in the US

alcon lumibird thumbnail
July 8, 2025

Alcon to Acquire LumiThera, Expanding into Dry AMD Treatment

Aflib_8_mg_6_months_intervals_in_EU_ _thumbnail
June 30, 2025

Eylea 8 mg Approved in EU for 6-Month Dosing in nAMD and DME

Discover our fascinating content at issuu

explore